The drugs can sometimes cost more than $1,000 per month out of pocket.
The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and ...
Sinar Daily on MSN
Health Ministry warns against unregistered 'weight-loss pens'
The ministry said Retatrutide remains an investigational drug currently undergoing Phase 3 clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results